GGHC
GNCA

Gilder Gagnon Howe & Co’s Genocea Biosciences, Inc. GNCA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,184
Closed -$65K – 277
2015
Q3 		$65K Hold
1,184
– – ﹤0.01% 240
2015
Q2 		$130K Buy
+1,184
New +$110K ﹤0.01% 252

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Gilder Gagnon Howe & Co's GNCA Position: Q4 2015 in Review

Gilder Gagnon Howe & Co sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2015, closing a stake of 1,184 shares — an estimated $65K sold.

Gilder Gagnon Howe & Co first reported a position in GNCA in Q2 2015 and held it in 2 quarters. The position peaked at $130K in Q2 2015. 57 funds tracked by Wall St. Rank hold GNCA as of Q4 2015.

  • Gilder Gagnon Howe & Co reported no remaining Genocea Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 1,184 Genocea Biosciences, Inc. shares in Q4 2015, an estimated $65K.
  • Gilder Gagnon Howe & Co first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's Genocea Biosciences, Inc. position peaked at $130K in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2015, filed 4 Feb 2016.